CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM) (“Enumeral” or the “Company”), a biotechnology company focused on discovering and developing novel antibody immunotherapies that help the immune system fight cancer and other diseases, today announced that Arthur H. Tinkelenberg, Ph.D., Enumeral’s President and Chief Executive Officer, will participate in the 2016 East/West CEO Conference on the panel entitled “Academia and Industry: Challenges and Synergies,” on Sunday, January 10, 2016 at 1:30 p.m. Pacific Time. The conference will be held at the Four Seasons Hotel in San Francisco, CA.
